Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility of AC/EC followed by weekly paclitaxel in node-positive breast cancer in Japan.
Ishikawa T, Shimizu S, Katayama K, Chishima T, Hamaguchi Y, Doi T, Tanabe M, Kasahara A, Yamaguchi N, Narui K, Ohta I, Matsumoto C, Shimizu D, Kito A, Suda T, Inaba M, Asaga T, Momiyama N, Ichikawa Y, Yoshimoto M, Morita S, Shimada H. Ishikawa T, et al. Among authors: shimizu d, shimizu s. Anticancer Res. 2009 May;29(5):1515-20. Anticancer Res. 2009. PMID: 19443359 Free article.
First-line Gemcitabine Versus Treatment of Physician's Choice for Metastatic Breast Cancer: A Prospective Cohort Study.
Yamamoto S, Narui K, Ishikawa T, Adachi S, Shimada K, Shimizu D, Yamada A, Sugae S, Tanabe M, Oba M, Morita S, Doi T, Hasegawa S, Morita T, Kito A, Chishima T, Ichikawa Y, Endo I; YOKOHAMA CLINCAL ONCOLOGY GROUP. Yamamoto S, et al. Among authors: shimizu d. Anticancer Res. 2021 Mar;41(3):1671-1676. doi: 10.21873/anticanres.14930. Anticancer Res. 2021. PMID: 33788764
473 results